Andean Precious Metals Corp. (CVE:APM – Get Free Report) rose 2.4% during trading on Wednesday . The company traded as high as C$1.31 and last traded at C$1.30. Approximately 144,071 shares changed hands during trading, a decline of 27% from the average daily volume of 196,891 shares. The stock had previously closed at C$1.27.
Analysts Set New Price Targets
Separately, Desjardins upgraded Andean Precious Metals to a “moderate buy” rating in a research note on Thursday, October 31st.
View Our Latest Research Report on Andean Precious Metals
Andean Precious Metals Stock Performance
Insider Activity at Andean Precious Metals
In related news, insider 2176423 Ontario Ltd. bought 84,400 shares of Andean Precious Metals stock in a transaction on Tuesday, October 8th. The stock was acquired at an average price of C$1.51 per share, with a total value of C$127,359.60. In the last three months, insiders have bought 1,202,800 shares of company stock worth $1,607,032. Company insiders own 69.37% of the company’s stock.
About Andean Precious Metals
Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases.
See Also
- Five stocks we like better than Andean Precious Metals
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Tesla Poised to Hit Record Highs This Holiday Season
- Why Invest in High-Yield Dividend Stocks?
- The Salesforce Rally is Just Getting Started: Here’s Why
- What is Forex and How Does it Work?
- 3 Chip and Data Center Stocks That Can Keep Rising in 2025
Receive News & Ratings for Andean Precious Metals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Andean Precious Metals and related companies with MarketBeat.com's FREE daily email newsletter.